HCPCS Level IIdrugActive
J9024
Inj atezolizumb 5mg hya-tqjs
BETOS: O1D
Effective: 2025-04-01
Description
Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tecentriq Hybreza
Manufacturer
Genentech, Inc.
HCPCS Dosage
5 MG
Billing Units
375.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.